Literature DB >> 21656108

[Treatment of disseminated granuloma annulare with anthralin].

M E Jantke1, H-P Bertsch, M P Schön, T Fuchs.   

Abstract

Granuloma annulare is a benign, often asymptomatic and self-limiting granulomatous skin disease. In cases of disseminated granuloma annulare, spontaneous regression is considerably less frequent than in localized forms so that therapy is often desired. Systemic treatments should always be assessed critically and reserved for patients who are severely affected and in whom treatment approaches with few side effects such as local application of anthralin do not suffice to achieve a satisfactory effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656108     DOI: 10.1007/s00105-011-2185-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  13 in total

1.  Cyclosporin for the treatment of granuloma annulare.

Authors:  P Fiallo
Journal:  Br J Dermatol       Date:  1998-02       Impact factor: 9.302

2.  The response of generalized granuloma annulare to dapsone.

Authors:  D B Czarnecki; D Gin
Journal:  Acta Derm Venereol       Date:  1986       Impact factor: 4.437

3.  PUVA therapy of diffuse granuloma annulare.

Authors:  T C Hindson; J G Spiro; H Cochrane
Journal:  Clin Exp Dermatol       Date:  1988-01       Impact factor: 3.470

4.  Sulfone treatment of granuloma annulare.

Authors:  A Steiner; H Pehamberger; K Wolff
Journal:  J Am Acad Dermatol       Date:  1985-12       Impact factor: 11.527

5.  Antimalarials for control of disseminated granuloma annulare in children.

Authors:  M Simon; P von den Driesch
Journal:  J Am Acad Dermatol       Date:  1994-12       Impact factor: 11.527

6.  The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria.

Authors:  Alison McGill; Adrian Frank; Nicola Emmett; Douglas M Turnbull; Mark A Birch-Machin; Nick J Reynolds
Journal:  FASEB J       Date:  2005-03-31       Impact factor: 5.191

Review 7.  [Granuloma annulare].

Authors:  L Kowalzick
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

8.  Disseminated granuloma annulare--treatment with fumaric acid esters.

Authors:  B Eberlein-König; M Mempel; J Stahlecker; I Forer; J Ring; D Abeck
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

9.  Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes.

Authors:  K N Schmidt; M Podda; L Packer; P A Baeuerle
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

10.  Response of generalized granuloma annulare to high-dose niacinamide.

Authors:  A Ma; M Medenica
Journal:  Arch Dermatol       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.